150 related articles for article (PubMed ID: 16619515)
21. Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy.
Ciekot J; Psurski M; Jurec K; Boratyński J
Invest New Drugs; 2021 Feb; 39(1):15-23. PubMed ID: 32643014
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia.
Stapf M; Pömpner N; Teichgräber U; Hilger I
Int J Nanomedicine; 2016; 11():485-500. PubMed ID: 26893557
[TBL] [Abstract][Full Text] [Related]
23. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
[TBL] [Abstract][Full Text] [Related]
24. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
25. Self-assembling water-soluble polymethacrylate-MTX conjugates: The significance of macromolecules architecture on drug conjugation efficiency, the final shape of particles, and drug release.
Bernaczek K; Mielańczyk A; Mielańczyk Ł; Neugebauer D; Grzywna ZJ
J Biomed Mater Res B Appl Biomater; 2019 Nov; 107(8):2476-2487. PubMed ID: 30773803
[TBL] [Abstract][Full Text] [Related]
26. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
[TBL] [Abstract][Full Text] [Related]
27. Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapy.
Goszczyński TM; Filip-Psurska B; Kempińska K; Wietrzyk J; Boratyński J
Pharmacol Res Perspect; 2014 Jun; 2(3):e00047. PubMed ID: 25505592
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization and in vitro evaluation of methotrexate conjugated fluorescent carbon nanoparticles as drug delivery system for human lung cancer targeting.
Ajmal M; Yunus U; Matin A; Haq NU
J Photochem Photobiol B; 2015 Dec; 153():111-20. PubMed ID: 26398818
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
31. PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex.
Jiang YY; Tang GT; Zhang LH; Kong SY; Zhu SJ; Pei YY
J Drug Target; 2010 Jun; 18(5):389-403. PubMed ID: 20055559
[TBL] [Abstract][Full Text] [Related]
32. Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.
Kosasih A; Bowman BJ; Wigent RJ; Ofner CM
Int J Pharm; 2000 Aug; 204(1-2):81-9. PubMed ID: 11011989
[TBL] [Abstract][Full Text] [Related]
33. A human leukemia cell culture system for testing new antifols: differential sensitivity of lymphoid and nonlymphoid cell lines to unconjugated and methotrexate-conjugated polymers of basic amino acids.
McGuire JJ; Russell CA
Leukemia; 1990 Jan; 4(1):48-52. PubMed ID: 2296201
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
[TBL] [Abstract][Full Text] [Related]
35. Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents.
Wei WH; Fountain M; Magda D; Wang Z; Lecane P; Mesfin M; Miles D; Sessler JL
Org Biomol Chem; 2005 Sep; 3(18):3290-6. PubMed ID: 16132091
[TBL] [Abstract][Full Text] [Related]
36. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
37. [Cancer chemotherapy for lymph nodal metastases using activated carbon particles adsorbing methotrexate].
Hagiwara A; Takahashi T; Sawai K; Shimotsuma M; Okano S; Sakakura C; Ozaki K; Tsujimoto H; Sasaki S; Shirasu M
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1595-7. PubMed ID: 1530314
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate-alpha-phenylalanine: optimization of methotrexate prodrug for activation by carboxypeptidase A-monoclonal antibody conjugate.
Vitols KS; Haag-Zeino B; Baer T; Montejano YD; Huennekens FM
Cancer Res; 1995 Feb; 55(3):478-81. PubMed ID: 7834611
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis.
Homma A; Sato H; Tamura T; Okamachi A; Emura T; Ishizawa T; Kato T; Matsuura T; Sato S; Higuchi Y; Watanabe T; Kitamura H; Asanuma K; Yamazaki T; Ikemi M; Kitagawa H; Morikawa T; Ikeya H; Maeda K; Takahashi K; Nohmi K; Izutani N; Kanda M; Suzuki R
Bioorg Med Chem; 2010 Feb; 18(3):1062-75. PubMed ID: 20060728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
